معرفی
Elodie Bal is a Research Professor at Université Paris Cité's Faculty of Medicine, Department of Dermatology, leading a research team focused on pediatric-onset inflammatory skin diseases and scleroderma mechanisms. Her laboratory operates in close collaboration with the clinical services of Hôpital Necker-Enfants Malades in Paris.
- Position: Team Leader
- Institutional Affiliation: Université Paris Cité / Hôpital Necker-Enfants Malades
- Research Funding: ATIP-Avenir program, French Society of Dermatology, French Scleroderma Association
Dr. Bal's research focuses on understanding the molecular and cellular mechanisms involved in dysregulated fibrogenesis, using scleroderma as a model to decipher pathological processes and identify new therapeutic targets. Her work spans genetics, epigenetics, and mechanisms of skin fibrosis with particular emphasis on pediatric-onset scleroderma cases.
Analysis of her recent publications reveals consistent research themes across dermatology, genetics, and molecular biology, with particular focus on genetic mutations underlying skin disorders, epithelial barrier dysfunction, and novel therapeutic approaches for fibrotic conditions. Her work bridges basic science with clinical applications, particularly for rare and severe pediatric skin diseases.
Her research team includes:
- Christine Bodemer (PU-PH)
- Smaïl Hadj-Rabia (PU-PH)
- Cecilia Taccagni (Doctoral student)
- Delphine Devin (Research engineer)
- Laura Polivka (Doctoral student)
Dr. Bal's laboratory has developed four main research axes:
- Identification of genetic alterations in severe pediatric scleroderma forms
- Decoding molecular and cellular mechanisms underlying patient phenotypes
- Analysis of signaling pathways and cells involved in fibrosis
- Development of 3D skin fibrosis models for therapeutic evaluation
